J&J to buy cancer therapy developer Halda Therapeutics for $3.05 billion
J&J(US:JNJ) Reuters·2025-11-17 13:07Johnson & Johnson said on Monday it would buy Halda Therapeutics for $3.05 billion in cash, expanding its presence in solid tumors and prostate cancer treatments. ...